University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, USA.
Department of Medicine and Epidemiology, Davis, CA 95616, USA,
J Avian Med Surg. 2023 Nov;37(3):209-216. doi: 10.1647/JAMS-D-22-00063.
Across the Americas, great horned owls () are often presented to veterinarians for conditions requiring pain management. Although recent studies have evaluated opioid drugs in raptor species, information in Strigiformes is lacking. The objective of this study was to evaluate the analgesic effect and duration of action of hydromorphone hydrochloride, a full µ-opioid receptor agonist, in great horned owls. In a randomized, blinded, balanced crossover study, 6 adult birds (5 females and 1 male) received hydromorphone (0.3 and 0.6 mg/kg) or saline (0.9% NaCl) solution (0.03 mL/kg; control) in the left pectoral muscle, with a 7-day washout interval between treatments. Each bird was assigned an agitation-sedation score, and the thermal foot withdrawal threshold (TFWT) was measured at predetermined times before ( = 0 hours) and after treatment administration ( = 0.5, 1.5, 3, and 6 hours). Measurements of the TFWT were obtained with a test box equipped with a thermal perch, which delivered a gradually increasing temperature 40-62°C (104-143.6°F) to the right plantar surface of the owl's foot. Compared with controls, hydromorphone at 0.3 mg/kg dose resulted in significantly higher mean TFWT at 0.5 hours ( < 0.001), 1.5 hours ( = 0.003), and 3 hours ( = 0.005), whereas the 0.6 mg/kg dose resulted in significantly higher mean TFWT from 0.5 hours ( = 0.035) to 1.5 hours ( = 0.001). Both hydromorphone doses were associated with a significant change in the agitation-sedation score ( = 0.001), consistent with mild to moderate sedation. Two owls were observed tremoring after administration of the 0.6 mg/kg dose, which was not noted after the 0.5-hour timepoint; no other adverse effects were identified. This study offers scientific evidence to support the use of a µ-opioid agonist in great horned owls for pain management. Pharmacokinetics and other pharmacodynamic studies of other pain models evaluating hydromorphone and other opioid drugs in this species are still needed.
在整个美洲,大角猫头鹰()经常被送到兽医那里治疗需要疼痛管理的疾病。尽管最近的研究已经评估了猛禽物种中的阿片类药物,但在 Strigiformes 中缺乏信息。本研究的目的是评估盐酸氢吗啡酮(一种完全μ-阿片受体激动剂)在大角猫头鹰中的镇痛效果和作用持续时间。在一项随机、盲法、平衡的交叉研究中,6 只成年鸟类(5 只雌性和 1 只雄性)接受了左胸肌注射氢吗啡酮(0.3 和 0.6 mg/kg)或生理盐水(0.9%NaCl)溶液(0.03 mL/kg;对照组),两次治疗之间有 7 天的洗脱期。每只鸟都被分配了一个激动-镇静评分,并且在治疗前(=0 小时)和治疗后(=0.5、1.5、3 和 6 小时)的预定时间测量热足退缩阈值(TFWT)。TFWT 的测量是使用一个带有热支的测试箱进行的,该测试箱向猫头鹰脚部的足底表面逐渐输送 40-62°C(104-143.6°F)的温度。与对照组相比,0.3 mg/kg 剂量的氢吗啡酮在 0.5 小时(<0.001)、1.5 小时(=0.003)和 3 小时(=0.005)时导致 TFWT 显著升高,而 0.6 mg/kg 剂量从 0.5 小时(=0.035)到 1.5 小时(=0.001)时导致 TFWT 显著升高。两种氢吗啡酮剂量都与激动-镇静评分的显著变化相关(=0.001),与轻度至中度镇静一致。两只猫头鹰在给予 0.6 mg/kg 剂量后出现震颤,而在 0.5 小时后未出现震颤;未发现其他不良反应。本研究为在大角猫头鹰中使用μ-阿片激动剂治疗疼痛提供了科学依据。在该物种中,仍需要评估其他疼痛模型中的氢吗啡酮和其他阿片类药物的药代动力学和其他药效动力学研究。